Zsolt I.
- Country
- Denmark
- Department
- Neurolog
Research Overview
- Long-term Safety and Tolerability of Tolebrutinib in Relapsing and Progressive Multiple Sclerosis: A Phase 3 Extension Study
- Phase 3 Extension Study on Long-term Safety and Tolerability of Tolebrutinib in Relapsing and Progressive Multiple Sclerosis
- Non-Inferiority Trial of Ocrelizumab Versus Rituximab in Active Multiple Sclerosis Patients
Data & Insights
Has run more than one trial at 6 of 158 partner sites.
Specializations
Multiple Sclerosis Research
The investigator specializes in the study of multiple sclerosis, with particular focus on both relapsing multiple sclerosis (RMS) and progressive multiple sclerosis (PMS) forms of the disease.
- Treatment Evaluation
- Long-term Safety Assessment
- Disease Progression Monitoring
Their research encompasses comparative studies of different therapeutic approaches for active multiple sclerosis management.
Neurological Disorders
The investigator conducts research in nervous system diseases with a specialized focus on therapeutic interventions and treatment methodologies.
- Disease Monitoring
- Treatment Tolerability
- Long-term Patient Outcomes
Their work includes evaluation of white matter lesions and advanced imaging techniques in neurological conditions.
Therapeutic Innovation
The investigator evaluates novel therapeutic approaches in neurological treatment, including comparative assessment of different treatment protocols.
- Extended Interval Dosing
- Treatment Comparison Studies
- Long-term Efficacy Assessment
Their research includes investigation of standard and modified dosing strategies in neurological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.